CRT 2026

Panel Discussion | Finding the Suitable Patient for TEER

Moderator(s)

• 

  Anita W. Asgar, MD, FACC, FSCAI

  Interventional Cardiologist
  Northwestern Medicine
  Chicago, Illinois, United States

  Disclosure information not submitted.
• 

  Scott Lim, MD

  Professor of Medicine
  University of British Columbia
  Vancouver, British Columbia, Canada

  Disclosure information not submitted.
• 

  Michael J. Rinaldi, MD

  Director Structural Heart Program
  Sanger Heart and Vascular Institute/Atrium Health
  Charlotte, North Carolina, United States

  Disclosure(s): PiCardia: Consulting Fees (e.g., advisory boards) (Ongoing)

Panel Discussant(s)

• 

  Chirag Bavishi, MD, MPH

  Director, Structural Heart Program
  University of Missouri at Columbia

  Disclosure(s): No financial relationships to disclose
• 

  Colin Barker, Sr., MD

  Director
  VUMC
  Nashville, Tennessee, United States

  Disclosure information not submitted.
• 

  Anthony DeMaria, MD

  Judy and Jack White Chair in Cardiology
  University of California, San Diego
  La Jolla, California, United States

  Disclosure(s): Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vivasure, Zoll: Grant/Research Support (Ongoing)
• 

  Antonio Frangieh, MD

  Medical Director Structural Heart Program, Associate Professor of Medicine
  University Of California Irvine
  Orange, California, United States

  Disclosure(s): Edward Lifesciences: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Christian Hengstenberg, MD

  Head of Department
  Medical University of Vienna
  Vienna, Austria

  Disclosure(s): Abbott Cardiovascular Systems: Grant/Research Support (Ongoing); Boston Scietific: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Jonathan Schwartz, MD

  Enterprise Director of Cardiovascular Innovation, Structural Interventional Cardiologist
  Sanger Heart & Vascular Institute, North Carolina, United States

  Disclosure information not submitted.